QDIS Blog

A blog about chemistry, drug development, science, and technology

January 4, 2007

Eli Lilly Settling More Zyprexa Lawsuits

by @ 2:50 pm.  Filed under Pharma News

It is reported today that LIlly is settling even more lawsuits related to Zyprexa. They are settling over 8,000 claims for $700 million which comes to $87,500 per claim. THere are an additional 1,200 claims that Lilly will fight in court. No reasons were given for this other than the reasons were varied.

Eli Lilly settling more Zyprexa suits - Yahoo! News

What is interesting is this quote from LIlly CEO, Sidney Taurel.

“While we remain confident that these claims are without merit, we took this difficult step because we believe it is in the best interest of the company, the patients who depend on this medication, and their physicians.”

This sort of phraseology is used some commonly in circumstances where companies have been irresponsible that it basically translates to “We know we did something wrong, we’ve paid off those affected, but we refuse to take responsibility and say we were wrong.”

It would be interesting to see how often these words or ones very similar have been uttered. I’m betting it could be found in company statements from many product liability lawsuits such as the tobacco industry, the asbestos lawsuits, the Ford Pinto cars and I’m sure many more. It is disconcerting to me to see this sort of attitude be so prevalent in American companies today especially in companies with such an impact on peoples life such as the pharmaceutical industry.

Technorati Tags: , ,

Email Ed Vawter



Related Posts:
  • Eli Lilly to Acquire Icos for $2.1B Finance
  • Eli Lilly and Zyprexa
  • Lilly and OSI Pharmaceuticals Announce Licensing Agreement
  • Genentech to buy Tanox for $919M in cash
  • More M&A Pharma Activity: Lilly to Acquire Hypnion

  • Bookmark it with: | del.icio.us del.icio.us | Digg It Digg it | Furl Furl | Simpy Simpy | Spurl Spurl | My! Yahoo My Yahoo! |

    2 Responses to “Eli Lilly Settling More Zyprexa Lawsuits”

    1. Daniel Haszard Says:

      Many of the longtime zyprexa users like myself who developed diabetes were given it ‘off label’ because it was being pushed on my doctor by Lilly drug reps.

      The now notorious Zyprexa diabetes connection is elaborated at thousands of pages on line.
      My own local clinic and clinics everywhere have stopped dispensing Zyprexa except as a PRN for acute cases.

      Eli Lilly’s zyprexa gravy train will stall soon enough.
      I am Daniel Haszard 4 year zyprexa user who got diabetes from it.

      Lilly made a mistake motivated by a desire for profits (greed) now it’s time to face the music.Lilly occasionally comes out with theses periodic media PR’s on compensation then nothing happens and you wonder why victims get indignant.

      Daniel Haszard www.zyprexa-victims.com

    2. Ed Vawter Says:

      Daniel, I can understand peoples feelings towards LIlly on this, but I think the doctors who prescribed it off label are also to blame. While I am in favor of off-label prescribing being allowed, I do think that it should be reserved for mainly life threatening conditions or for situations where no other drug works. In my opinion, there in already proven drugs and using drugs for un-approved conditions should not be done except in extreme situations. Doctors are far too ready to prescribe any pill without weighing the risk vs. reward.

    Leave a Reply

    [powered by WordPress.]

    QDIS: blogging about chemistry, drug development, science and technology.

    Internal Links

    Categories

    Search This Blog

    Archives

    January 2007
    S M T W T F S
    « Dec   Feb »
     123456
    78910111213
    14151617181920
    21222324252627
    28293031  

    Search Entire Site

    Subscribe (It's Free!)

    Performancing

    Chemistry, science, and technology for the future.

    logo2

    General Links

    Blog Links

    Chemistry Journal Feeds

    Chemistry Feeds

    35 queries. 1.107 seconds